Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387399183> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4387399183 abstract "Background and Purpose In patients with myasthenia gravis (MG), worsening of symptoms poses a risk of respiratory failure which can be precipitated by medication use. Although purported, the risks associated with administration of certain medications are not fully elucidated. Thus, clinical decision support involving a best practice alert was executed to caution providers of drug-disease interactions when ordering a potentially harmful medication. We performed an analysis of the alert overrides with subsequent medication exposure to determine the incidence of MG exacerbations. Methods This retrospective chart-review evaluated adult patients with MG at 2 large academic medical centers via electronic health records between November-2019 and November-2021 who received a medication following override of the clinical decision support tool. The primary outcome was proportion of patient encounters complicated by myasthenic exacerbations after potentially harmful medication administration. Secondary outcomes included changes in motor strength, length of stay, discharge disposition, unplanned level-of-care escalations, and changes to immunosuppressant therapy following medication administration. Results A total of 70 orders were assessed in 38 patients across 55 encounters. Medications administered during these encounters included macrolides, fluoroquinolones, β-blockers, calcium channel blockers, and magnesium sulfate. Exacerbation of disease occurred in 7 patient encounters (12.7%) and occurred after intravenous magnesium or intravenous labetalol. In 5/7 events, at least 1 other risk factor associated with a myasthenic exacerbation was present. Conclusions Of the medications reported to potentially worsen MG, intravenous labetalol and intravenous magnesium were the 2 agents associated with myasthenic exacerbations with a higher incidence in patients harboring additional risk factors." @default.
- W4387399183 created "2023-10-07" @default.
- W4387399183 creator A5047982417 @default.
- W4387399183 creator A5059333533 @default.
- W4387399183 creator A5093016032 @default.
- W4387399183 date "2023-10-06" @default.
- W4387399183 modified "2023-10-07" @default.
- W4387399183 title "Evaluation of Medication Exposure on Exacerbation of Disease in Patients With Myasthenia Gravis" @default.
- W4387399183 cites W1856411233 @default.
- W4387399183 cites W2016628207 @default.
- W4387399183 cites W2067978628 @default.
- W4387399183 cites W2132107136 @default.
- W4387399183 cites W2312735779 @default.
- W4387399183 cites W3049767438 @default.
- W4387399183 cites W4206474848 @default.
- W4387399183 doi "https://doi.org/10.1177/19418744231206256" @default.
- W4387399183 hasPublicationYear "2023" @default.
- W4387399183 type Work @default.
- W4387399183 citedByCount "0" @default.
- W4387399183 crossrefType "journal-article" @default.
- W4387399183 hasAuthorship W4387399183A5047982417 @default.
- W4387399183 hasAuthorship W4387399183A5059333533 @default.
- W4387399183 hasAuthorship W4387399183A5093016032 @default.
- W4387399183 hasConcept C120665830 @default.
- W4387399183 hasConcept C121332964 @default.
- W4387399183 hasConcept C126322002 @default.
- W4387399183 hasConcept C177713679 @default.
- W4387399183 hasConcept C187212893 @default.
- W4387399183 hasConcept C194828623 @default.
- W4387399183 hasConcept C195910791 @default.
- W4387399183 hasConcept C2777014857 @default.
- W4387399183 hasConcept C2778105408 @default.
- W4387399183 hasConcept C2779134260 @default.
- W4387399183 hasConcept C61511704 @default.
- W4387399183 hasConcept C71924100 @default.
- W4387399183 hasConceptScore W4387399183C120665830 @default.
- W4387399183 hasConceptScore W4387399183C121332964 @default.
- W4387399183 hasConceptScore W4387399183C126322002 @default.
- W4387399183 hasConceptScore W4387399183C177713679 @default.
- W4387399183 hasConceptScore W4387399183C187212893 @default.
- W4387399183 hasConceptScore W4387399183C194828623 @default.
- W4387399183 hasConceptScore W4387399183C195910791 @default.
- W4387399183 hasConceptScore W4387399183C2777014857 @default.
- W4387399183 hasConceptScore W4387399183C2778105408 @default.
- W4387399183 hasConceptScore W4387399183C2779134260 @default.
- W4387399183 hasConceptScore W4387399183C61511704 @default.
- W4387399183 hasConceptScore W4387399183C71924100 @default.
- W4387399183 hasLocation W43873991831 @default.
- W4387399183 hasOpenAccess W4387399183 @default.
- W4387399183 hasPrimaryLocation W43873991831 @default.
- W4387399183 hasRelatedWork W1985127333 @default.
- W4387399183 hasRelatedWork W2005139163 @default.
- W4387399183 hasRelatedWork W2091716289 @default.
- W4387399183 hasRelatedWork W2418216271 @default.
- W4387399183 hasRelatedWork W2433746147 @default.
- W4387399183 hasRelatedWork W2921987722 @default.
- W4387399183 hasRelatedWork W3031767843 @default.
- W4387399183 hasRelatedWork W4237377959 @default.
- W4387399183 hasRelatedWork W596128687 @default.
- W4387399183 hasRelatedWork W2020959891 @default.
- W4387399183 isParatext "false" @default.
- W4387399183 isRetracted "false" @default.
- W4387399183 workType "article" @default.